159 related articles for article (PubMed ID: 10992722)
1. The relationship between virological characteristics of hepatitis C virus (HCV) and reactivity to the regional specific proteins of HCV.
Yoon SK; Park YM; Byun BH; Bae SH; Yang JM; Ahn BM; Lee YS; Lee CD; Sun HS; Kim BS
Korean J Intern Med; 2000 Jul; 15(2):109-16. PubMed ID: 10992722
[TBL] [Abstract][Full Text] [Related]
2. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus replication and antibody responses toward specific hepatitis C virus proteins.
Yuki N; Hayashi N; Kasahara A; Hagiwara H; Ohkawa K; Fusamoto H; Kamada T
Hepatology; 1994 Jun; 19(6):1360-5. PubMed ID: 7514560
[TBL] [Abstract][Full Text] [Related]
4. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
Chu CM; Sheen IS; Liaw YF
Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
[TBL] [Abstract][Full Text] [Related]
5. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
[TBL] [Abstract][Full Text] [Related]
6. Relation between reactivity to the NS-4 region peptides of hepatitis C virus (HCV) and clinical features among patients infected with HCV genotype 1b.
Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Kinjo F; Saito A; Nakayoshi T; Yamashiro A
Microbiol Immunol; 1998; 42(4):299-303. PubMed ID: 9623917
[TBL] [Abstract][Full Text] [Related]
7. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
[TBL] [Abstract][Full Text] [Related]
8. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
Chu CM; Sheen IS; Liaw YF
Scand J Gastroenterol; 2004 Aug; 39(8):778-82. PubMed ID: 15513365
[TBL] [Abstract][Full Text] [Related]
9. Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA.
Pawlotsky JM; Fleury A; Choukroun V; Deforges L; Roudot-Thoraval F; Aumont P; Duval J; Dhumeaux D
J Clin Microbiol; 1994 May; 32(5):1357-9. PubMed ID: 7519631
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
[TBL] [Abstract][Full Text] [Related]
11. Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay.
Pawlotsky JM; Bastie A; Pellet C; Remire J; Darthuy F; Wolfe L; Sayada C; Duval J; Dhumeaux D
J Clin Microbiol; 1996 Jan; 34(1):80-3. PubMed ID: 8748278
[TBL] [Abstract][Full Text] [Related]
12. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.
Neville JA; Prescott LE; Bhattacherjee V; Adams N; Pike I; Rodgers B; El-Zayadi A; Hamid S; Dusheiko GM; Saeed AA; Haydon GH; Simmonds P
J Clin Microbiol; 1997 Dec; 35(12):3062-70. PubMed ID: 9399495
[TBL] [Abstract][Full Text] [Related]
13. Changes in antibodies to specific hepatitis C virus antigens with interferon-alpha therapy: analysis by recombinant immunoblot assay.
Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
Am J Gastroenterol; 1993 Jun; 88(6):914-8. PubMed ID: 7684885
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis.
Saracco G; Abate ML; Baldi M; Calvo PL; Manzini P; Brunetto MR; Oliveri F; Kuo G; Chien D; Houghton M
Liver; 1994 Apr; 14(2):65-70. PubMed ID: 7515141
[TBL] [Abstract][Full Text] [Related]
15. [Second generation hepatitis-C virus test and polymerase chain reaction in anti-C 100 negative patients with chronic non-A, non-B hepatitis].
Zala G; Havelka J; Wicki AN; Joller-Jemelka HI; Meier B; Schmid M; Bühler H
Schweiz Med Wochenschr; 1992 Mar; 122(11):363-8. PubMed ID: 1313601
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction.
Kanesaki T; Kinoshita S; Tsujino G; Yoshioka K; Ikegami N
J Pediatr; 1993 Sep; 123(3):381-7. PubMed ID: 7689096
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus genotypes, reactivity to recombinant immunoblot assay 2 antigens and liver disease.
Ichimura H; Tamura I; Kurimura O; Koda T; Mizui M; Tsuchie H; Kurimura T
J Med Virol; 1994 Jul; 43(3):212-5. PubMed ID: 7523579
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus serotype-specific core and NS4 antibodies in injecting drug users participating in the Amsterdam cohort studies.
Beld M; Penning M; van Putten M; van den Hoek A; Lukashov V; McMorrow M; Goudsmit J
J Clin Microbiol; 1998 Oct; 36(10):3002-6. PubMed ID: 9738057
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C viral clearance and antibody reactivity patterns in persons with haemophilia and other congenital bleeding disorders.
Messick K; Sanders JC; Goedert JJ; Eyster ME
Haemophilia; 2001 Nov; 7(6):568-74. PubMed ID: 11851755
[TBL] [Abstract][Full Text] [Related]
20. Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: effects of hepatitis B virus co-infection and interferon treatment.
Zampino R; Marrone A; Durante Mangoni E; Santarpia L; Sica A; Tripodi MF; Utili R; Ruggiero G; Adinolfi LE
J Med Virol; 2004 May; 73(1):33-7. PubMed ID: 15042645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]